May 8 (Reuters) - Aeglea Bio Therapeutics Inc:
* AEGLEA BIOTHERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS
* AS OF MARCH 31, 2018, AEGLEA HAD AVAILABLE CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $43.5 MILLION
* CO BELIEVES IT HAS SUFFICIENT CAPITAL RESOURCES TO FUND ANTICIPATED OPERATIONS THROUGH THE MIDDLE OF 2020 Source text for Eikon: Further company coverage:
